We are live on ! Find out more
U

UBS Portfolio holdings

AUM $136B
1-Year Est. Return 16.36%
This Fund
S&P 500
This Quarter Est. Return
+8.25%
1 Year Est. Return
+16.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$107B
AUM Growth
+$9.22B
Cap. Flow
+$1.49B
Cap. Flow %
1.39%
Top 10 Hldgs %
13.06%
Holding
11,531
New
1,148
Increased
4,823
Reduced
3,924
Closed
1,123

Sector Composition

Rank Sector Weight
1 Energy 8.45%
2 Healthcare 6.45%
3 Technology 6.41%
4 Financials 6.11%
5 Industrials 5.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HNH
7376
DELISTED
Handy & Harman Holdings Ltd.
HNH
$36K ﹤0.01%
1,508
+83
+6% +$1.96K
FCH.PRA
7377
DELISTED
Felcor Lodging Tr Ser A Cum Cv
FCH.PRA
$36K ﹤0.01%
1,494
+1,194
+398% +$28.4K
XUE
7378
DELISTED
XUEDA EDUCATION GROUP ADS REPTG 2 ORD SHS
XUE
$36K ﹤0.01%
+5,800
New +$30.4K
DEFL
7379
DELISTED
DEUTSCHE BK AG LONDON BRH POWERSHARES DB US DEFLATION
DEFL
$36K ﹤0.01%
700
NIHD
7380
CALL
DELISTED
NII HOLDINGS INC CL B
NIHD
$36K ﹤0.01%
13,200
-8,900
-40% -$32.8K
GCVRZ
7381
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$36K ﹤0.01%
106,985
-12,661
-11% -$15.3K
PGD
7382
DELISTED
iPath Asian & Gulf Currency Revaluation ETN
PGD
$36K ﹤0.01%
716
AMKR icon
7383
Amkor Technology
AMKR
$12.7B
$35K ﹤0.01%
5,803
-27,146
-82% -$145K
ATHE
7384
CALL
Alterity Therapeutics
ATHE
$78.7M
$35K ﹤0.01%
+83
New +$24.8K
ATHE
7385
Alterity Therapeutics
ATHE
$78.7M
$35K ﹤0.01%
85
+52
+158% +$15.6K
BCRX icon
7386
PUT
BioCryst Pharmaceuticals
BCRX
$2.33B
$35K ﹤0.01%
4,600
+1,600
+53% +$10.1K
BELFB
7387
Bel Fuse Inc Class B
BELFB
$3.96B
$35K ﹤0.01%
1,663
+490
+42% +$9.95K
BLDP
7388
Ballard Power Systems
BLDP
$853M
$35K ﹤0.01%
23,515
+2,475
+12% +$3.53K
DIG icon
7389
PUT
ProShares Ultra Energy
DIG
$81.9M
$35K ﹤0.01%
+400
New +$32.7K
ENS icon
7390
PUT
EnerSys
ENS
$6.92B
$35K ﹤0.01%
500
-2,000
-80% -$134K
IDT icon
7391
IDT Corp
IDT
$1.64B
$35K ﹤0.01%
2,777
+424
+18% +$5.99K
KG
7392
Kestrel Group
KG
$67.1M
$35K ﹤0.01%
161
-74
-31% -$17.3K
MOH icon
7393
CALL
Molina Healthcare
MOH
$10.1B
$35K ﹤0.01%
1,000
-4,200
-81% -$142K
MOH icon
7394
PUT
Molina Healthcare
MOH
$10.1B
$35K ﹤0.01%
+1,000
New +$33.7K
NEN icon
7395
New England Realty Associates
NEN
$199M
$35K ﹤0.01%
769
+709
+1,182% +$31.7K
PACB icon
7396
CALL
Pacific Biosciences
PACB
$453M
$35K ﹤0.01%
6,600
-2,200
-25% -$10.1K
PLX icon
7397
PUT
Protalix BioTherapeutics
PLX
$189M
$35K ﹤0.01%
910
-34,570
-97% -$1.46M
SCHX icon
7398
CALL
Schwab US Large- Cap ETF
SCHX
$71.5B
$35K ﹤0.01%
4,800
+3,000
+167% +$21.1K
SOXL icon
7399
CALL
Direxion Daily Semiconductor Bull 3X ETF
SOXL
$17.9B
$35K ﹤0.01%
37,500
+22,500
+150% +$17.6K
SSL icon
7400
CALL
Sasol
SSL
$7.44B
$35K ﹤0.01%
700
+300
+75% +$14.8K

Similar funds

UBS's Q4 2013 Portfolio in Review

As of Q4 2013, UBS held 11,531 positions worth $107B, up 9.4% from $97.7B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS's Q4 2013 filing shows 1,148 new, 4,823 increased, 3,924 reduced and 1,123 closed positions. Its largest new stake was American Airlines Group: 670,542 shares worth $16.9M. The largest sale was TALISMAN ENERGY INC, an estimated $615M.

By sector, the portfolio is most concentrated in Energy at 8.5% of assets, down from 9.1% a quarter earlier, followed by Healthcare and Technology.

  • UBS's largest Q4 2013 buy was American Airlines Group: 670,542 shares worth $16.9M.
  • UBS added most to State Street SPDR S&P 500 ETF Trust in Q4 2013, an estimated $1.56B increase.
  • UBS's biggest Q4 2013 reduction was TALISMAN ENERGY INC, cutting an estimated $615M.
  • UBS fully exited NYSE EURONEXT INC in Q4 2013, selling an estimated $110M.
  • UBS's ten largest holdings make up 13% of its $107B portfolio in Q4 2013.
  • UBS opened 1,148 new positions and closed 1,123 in Q4 2013.
  • UBS's portfolio value rose 9.4% quarter-over-quarter to $107B.

Based on UBS's 13F filing for Q4 2013, filed 14 Feb 2014.